Suboxone can remain detectable for several days after the last dose. Published urine estimates vary by laboratory, with buprenorphine often detectable for about a week and sometimes longer. A standard opiate screen does not reliably detect it; the panel needs a specific buprenorphine test.
Those numbers are estimates, and the real window depends on dose, how long someone has been taking it, and how their body processes medicine. People in buprenorphine treatment with regular clinical monitoring are often tested for it on purpose, so a positive result there is expected.
How Long Does Suboxone Stay in Your System?
Suboxone contains buprenorphine and naloxone. Buprenorphine attaches to opioid receptors to ease withdrawal symptoms and treat opioid addiction, while naloxone blocks opioid effects mainly if the medicine is misused.
The best guide is buprenorphine’s half-life, the time it takes the body to clear half of a dose. The FDA label for Suboxone lists a mean elimination half-life of 24 to 42 hours for buprenorphine [1]. The label lists a much shorter half-life for naloxone, the opioid antagonist in the medicine, at about 2 to 12 hours.
A common rule of thumb in pharmacology is that a drug is mostly cleared after about five half-lives. Applied to buprenorphine, that works out to roughly 5 to 9 days for the medicine itself. Its long half-life is also why many people take Suboxone once a day.
That slow clearance does not make stopping painless. Suboxone should not be stopped abruptly, because withdrawal symptoms can still appear as levels fall, so any plan to stop is made with the prescriber.
Buprenorphine is the active medicine in both daily films and buprenorphine-only tablets, but formulation and dose can affect detection. Long-acting injections have much longer timelines than daily films. Our chapter on subutex vs suboxone explains how the daily products differ.
Detection Windows by Test Type
How long Suboxone remains detectable depends on what is being tested, and results vary based on the sample and the lab. Urine is the most common sample, and it has the clearest published estimates.
Urine Tests
Mayo Clinic Laboratories lists an approximate urine detection time of up to 7 days for both buprenorphine and norbuprenorphine [2]. Norbuprenorphine is the main breakdown product the liver makes from buprenorphine. Labs can detect buprenorphine itself and its different metabolites, and they look for norbuprenorphine because it shows the medicine actually passed through the body.
ARUP’s current online reference lists an estimated urine window of 1 to 10 days for buprenorphine [3]. Mayo lists up to 7 days for buprenorphine and norbuprenorphine. These are estimates, not guaranteed clearance deadlines; assay sensitivity, dose, frequency of use, and metabolism affect results.
Slow elimination and the continued presence of metabolites help explain the detection window. Our guide to how Suboxone works explains the medicine’s long-lasting action.
Blood, Saliva, and Hair Tests
Blood tests and saliva tests generally look at a shorter window than urine, since they measure what is circulating at the time of the test. They are used less often for buprenorphine and are more common in emergency or medical settings than in routine screening.
Hair tests can reflect use over a much longer period, because drugs are trapped in hair as it grows. They are a less common way to check for buprenorphine in treatment, and results depend heavily on the lab and the method used.
Does Suboxone Show Up on a Drug Test?
Suboxone shows up only when the test is designed to look for buprenorphine. Buprenorphine is a partial opioid agonist with a different chemical structure from the other opioids that common drug tests screen for, so a basic opioid screen often misses it.
A positive result also says nothing about whether someone felt any effect, and the question of whether Suboxone gets you high is a separate one.
Standard 5-Panel and Workplace Drug Tests
The federal Department of Transportation panel is a useful example of a standard drug test. Since January 1, 2018, its opioid category has covered codeine, morphine, heroin’s marker 6-AM, hydrocodone, hydromorphone, oxycodone, and oxymorphone [4]. Buprenorphine is an opioid medication, but it is not on that list, so it would not be reported on that panel.
Larger 10-panel and 12-panel tests vary by lab and by employer. Some include buprenorphine, and many do not.
Employment screening and pre-employment panels vary, and an employer can add buprenorphine to the drug panels it orders. If you need to know, the employer or testing company can tell you which substances a particular panel includes.
When Buprenorphine Is Tested On Purpose
Programs that provide treatment for opioid use disorder often test for buprenorphine as part of clinical monitoring. A positive result supports recent exposure, but one urine result cannot prove that every dose was taken as prescribed. Results are interpreted alongside metabolites, sample validity, and the clinical history.
A licensed provider may order these tests at the start of Suboxone treatment and at follow-up visits, which also helps prevent misuse.
Courts, probation offices, and pain clinics may also order tests that include buprenorphine. People sent for testing by a pain clinic often wonder about something else, and we answer does Suboxone help with pain in its own chapter.
What Affects How Long Suboxone Stays Detectable
Several factors tied to Suboxone use and to the body itself can make buprenorphine remain detectable longer or clear faster:
- Dose and length of use. Higher doses and steady daily use build up more medicine and breakdown products than a single dose.
- Liver function. The liver processes buprenorphine, so liver disease can slow clearance. The label advises against using these products in people with severe liver disease.
- Other prescription medications. Drugs that slow or speed the liver enzyme CYP3A4 can change buprenorphine levels, and the label calls for monitoring when those drugs are started or stopped.
- Age and body makeup. Buprenorphine is stored in fatty tissue, and older adults may clear some medicines more slowly.
- Formulation. Long-acting buprenorphine injections given monthly stay in the body far longer than a daily film.
Some of those same interactions also raise safety concerns. Mixing buprenorphine with sedatives or alcohol is the biggest one, and the risks of taking too much or mixing Suboxone with other drugs are covered in a separate chapter.
Your Rights: Prescriptions, Employers, and Test Results
Having a valid prescription changes what a positive result means. In federally regulated testing, a medical review officer, a physician who reviews lab results, contacts the person about any positive result and asks about legal prescriptions before reporting it to an employer. Quick immunoassay screens can also produce false positives, and a lab confirmation test identifies the exact substance.
The Americans with Disabilities Act generally protects eligible people taking prescribed medication for OUD under professional supervision. DOJ guidance says an employer cannot deny or end employment simply because of this legal treatment, although inability to perform the job safely and effectively or disqualification under another federal law can affect eligibility [5].
The ADA’s current-illegal-drug-use exclusion can apply when an employment action is based on that use; lawful prescribed OUD treatment is not illegal drug use. The ADA National Network also answers workplace-rights questions. Our post on whether you can be fired for going to rehab explains related protections.
How Long Does Suboxone Stay in Your System? Frequently Asked Questions
How Long Does Suboxone Stay in Your Urine?
Laboratory estimates differ: Mayo lists up to 7 days for buprenorphine and norbuprenorphine, while ARUP’s current table gives a 1 to 10 day window for buprenorphine. Dose, regular use, liver function, other medicines, and the test’s sensitivity affect results. These estimates cannot tell you exactly when your own test will become negative.
Will Suboxone Show Up on a Standard 10-Panel Drug Test?
It depends on the lab, since many 10-panel tests do not include buprenorphine, while others add it as one of the ten substances. Suboxone appears on a result only when buprenorphine is specifically on the panel. Asking the employer or the testing company which substances are included is the most reliable way to know ahead of time.
Does a Workplace Drug Test Check for Buprenorphine?
Many standard workplace tests, including DOT testing, do not include buprenorphine, but expanded panels may. A valid prescription should be reviewed through the applicable testing process. The ADA generally protects lawful OUD treatment, subject to coverage, ability to perform the job safely, and other federal qualification rules; a prescription does not guarantee eligibility for every role.
Getting Clear Answers About Suboxone and Testing
Questions about drug testing are common at the start of addiction treatment, and a prescriber can explain what to expect for your job, court case, or care plan. If you are in South Florida and want to talk about starting buprenorphine, Simple Path Recovery’s admissions team can walk you through the process.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Sources
- U.S. Food and Drug Administration. SUBOXONE (buprenorphine and naloxone) sublingual film, prescribing information. Revised December 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022410s057lbl.pdf
- Mayo Clinic Laboratories. Drug Book: Buprenorphine. https://www.mayocliniclabs.com/test-catalog/drug-book/specific-drug-groups/buprenorphine
- ARUP Laboratories. Drug Half-Lives and Urine Detection Windows. Updated January 2025. https://arupconsult.com/content/drug-half-lives-and-urine-detection-windows
- U.S. Department of Transportation, Office of Drug and Alcohol Policy and Compliance. DOT 5 Panel Notice. March 6, 2018. https://www.transportation.gov/odapc/DOT_5_Panel_Notice_2018
- U.S. Department of Justice, Civil Rights Division. The ADA and Opioid Use Disorder: Combating Discrimination Against People in Treatment or Recovery. April 5, 2022. https://www.ada.gov/resources/opioid-use-disorder/
